All Stories

  1. Design, Synthesis, and Evaluation of Novel Inhibitors of Aminoglycoside‐Resistance 16S Ribosomal RNA Methyltransferases
  2. KNexPHENIX: A PHENIX-Based Workflow for Improving Cryo-EM and Crystallographic Structural Models
  3. Mechanism of 30S subunit recognition and modification by the conserved bacterial ribosomal RNA methyltransferase RsmI
  4. Basis for selective drug evasion of an aminoglycoside-resistance ribosomal RNA modification
  5. Discovery of First-in-Class Inhibitors Targeting a Pathogen-Associated Aminoglycoside-Resistance 16S rRNA Methyltransferase
  6. Distant ribose 2′-O-methylation of 23S rRNA helix 69 pre-orders the capreomycin drug binding pocket at the ribosome subunit interface
  7. Regulation, structure, and activity of the Pseudomonas aeruginosa MexXY efflux system
  8. Determination of Pseudomonas aeruginosa MexXY-OprM substrate profile in a major efflux knockout system reveals distinct antibiotic substrate classes
  9. Distant Ribose 2’-O-Methylation of 23S rRNA Helix 69 Pre-Orders the Capreomycin Drug Binding Pocket at the Ribosome Subunit Interface
  10. Evading resistance at the double
  11. Determination ofPseudomonas aeruginosaMexXY-OprM substrate profile in a major efflux knockout system reveals distinct antibiotic substrate classes
  12. Structural and functional diversity of Resistance-Nodulation-Division (RND) efflux pump transporters with implications for antimicrobial resistance
  13. Ensuring a sustained workforce to combat antibiotic resistance in the 21st century: the critical need for training the next-gen of scientists at the pre-doctoral level
  14. Di-berberine conjugates as chemical probes of Pseudomonas aeruginosa MexXY-OprM efflux function and inhibition
  15. 30S subunit recognition and G1405 modification by the aminoglycoside-resistance 16S ribosomal RNA methyltransferase RmtC
  16. Di-berberine conjugates as chemical probes ofPseudomonas aeruginosaMexXY-OprM efflux function and inhibition
  17. 30S subunit recognition and G1405 modification by the aminoglycoside-resistance 16S ribosomal RNA methyltransferase RmtC
  18. tRNA m1G9 modification depends on substrate-specific RNA conformational changes induced by the methyltransferase Trm10
  19. Ribosome-targeting antibiotics and resistance via ribosomal RNA methylation
  20. 50S subunit recognition and modification by the Mycobacterium tuberculosis ribosomal RNA methyltransferase TlyA
  21. Role of helical structure and dynamics in oligoadenylate synthetase 1 (OAS1) mismatch tolerance and activation by short dsRNAs
  22. 50S subunit recognition and modification by the Mycobacterium tuberculosis ribosomal RNA methyltransferase TlyA
  23. Targeted Redesign of Suramin Analogs for Novel Antimicrobial Lead Development
  24. Targeted redesign of suramin analogs for novel antimicrobial lead development
  25. Antibiotic Substrate Selectivity of Pseudomonas aeruginosa MexY and MexB Efflux Systems Is Determined by a Goldilocks Affinity
  26. Human OAS1 activation is highly dependent on both RNA sequence and context of activating RNA motifs
  27. Substrate recognition by the Pseudomonas aeruginosa EF-Tu–modifying methyltransferase EftM
  28. Functionally critical residues in the aminoglycoside resistance-associated methyltransferase RmtC play distinct roles in 30S substrate recognition
  29. Substrate recognition by the Pseudomonas aeruginosa EF-Tu methyltransferase EftM
  30. Dysregulation of M segment gene expression contributes to influenza A virus host restriction
  31. Critical residues in the aminoglycoside-resistance 16S rRNA (m7G1405) methyltransferase RmtC play distinct roles in 30S substrate recognition
  32. Trimethylation of Elongation Factor-Tu by the Dual Thermoregulated Methyltransferase EftM Does Not Impact Its Canonical Function in Translation
  33. A human cellular noncoding RNA activates the antiviral protein 2’–5’-oligoadenylate synthetase 1
  34. Substrate Recognition and Modification by a Pathogen-Associated Aminoglycoside Resistance 16S rRNA Methyltransferase
  35. Human non-coding RNA 886 (nc886) adopts two structurally distinct conformers that are functionally opposing regulators of PKR
  36. A Novel Motif for S-adenosyl-L-methionine Binding by the Ribosomal RNA Methyltransferase TlyA from Mycobacterium tuberculosis
  37. Adenovirus VA RNA: An essential pro-viral non-coding RNA
  38. Functional dichotomy in the 16S rRNA (m 1 A1408) methyltransferase family and control of catalytic activity via a novel tryptophan mediated loop reorganization
  39. Heterologous Expression and Functional Characterization of the Exogenously Acquired Aminoglycoside Resistance Methyltransferases RmtD, RmtD2, and RmtG
  40. The Regulatory and Kinase Domains but Not the Interdomain Linker Determine Human Double-stranded RNA-activated Kinase (PKR) Sensitivity to Inhibition by Viral Non-coding RNAs
  41. The Pathogen-Derived Aminoglycoside Resistance 16S rRNA Methyltransferase NpmA Possesses Dual m1A1408/m1G1408 Specificity
  42. 30S Subunit-Dependent Activation of the Sorangium cellulosum So ce56 Aminoglycoside Resistance-Conferring 16S rRNA Methyltransferase Kmr
  43. A novel RNA molecular signature for activation of 2′-5′ oligoadenylate synthetase-1
  44. Plasmid Template Design and In Vitro Transcription of Short RNAs Within a “Structure Cassette” for Structure Probing Experiments
  45. General Protocols for Preparation of Plasmid DNA Template, RNA In Vitro Transcription, and RNA Purification by Denaturing PAGE
  46. Cis-Acting Ribozymes for the Production of RNA In Vitro Transcripts with Defined 5′ and 3′ Ends
  47. Identification of new inhibitors of protein kinase R guided by statistical modeling
  48. Reduced Sweetness of a Monellin (MNEI) Mutant Results from Increased Protein Flexibility and Disruption of a Distant Poly-(L-Proline) II Helix
  49. Expression, purification and crystallization of adenosine 1408 aminoglycoside-resistance rRNA methyltransferases for structural studies
  50. Magnesium-Dependent Interaction of PKR with Adenovirus VAI
  51. Structural insights into the function of aminoglycoside-resistance A1408 16S rRNA methyltransferases from antibiotic-producing and human pathogenic bacteria
  52. Heterologous Escherichia coli Expression, Purification and Characterization of the GrmA Aminoglycoside-Resistance Methyltransferase
  53. The PKR-binding domain of adenovirus VA RNAI exists as a mixture of two functionally non-equivalent structures
  54. Determination of the target nucleosides for members of two families of 16S rRNA methyltransferases that confer resistance to partially overlapping groups of aminoglycoside antibiotics
  55. Structure of the Thiostrepton Resistance Methyltransferase{middle dot}S-Adenosyl-L-methionine Complex and Its Interaction with Ribosomal RNA
  56. Aminoglycoside resistance genes sgm and kgmB protect bacterial but not yeast small ribosomal subunits in vitro despite high conservation of the rRNA A-site
  57. Critical Residues for Cofactor Binding and Catalytic Activity in the Aminoglycoside Resistance Methyltransferase Sgm
  58. Systematic Deletion of the Adenovirus-associated RNAI Terminal Stem Reveals a Surprisingly Active RNA Inhibitor of Double-stranded RNA-activated Protein Kinase
  59. Analysis of adenovirus VA RNAI structure and stability using compensatory base pair modifications
  60. Recombinant RNA expression
  61. Raman and Raman optical activity (ROA) analysis of RNA structural motifs in Domain I of the EMCV IRES
  62. Optimization of a Ribosomal Structural Domain by Natural Selection †
  63. Expression and Purification of Functional Ligand-Binding Domains of T1R3 Taste Receptors
  64. Distinct Contributions of T1R2 and T1R3 Taste Receptor Subunits to the Detection of Sweet Stimuli
  65. Coevolution of Protein and RNA Structures within a Highly Conserved Ribosomal Domain
  66. NMR studies of the structure and Mg2+ binding properties of a conserved RNA motif of EMCV picornavirus IRES element
  67. Conserved Nucleotides within the J Domain of the Encephalomyocarditis Virus Internal Ribosome Entry Site Are Required for Activity and for Interaction with eIF4G
  68. General plasmids for producing RNA in vitro transcripts with homogeneous ends
  69. The solution structure of a DNAmiddle dotRNA duplex containing 5-propynyl U and C; comparison with 5-Me modifications
  70. A Compact RNA Tertiary Structure Contains a Buried Backbone–K+ Complex